TRT myths vs. reality: what Brazilian TikTok gets right and wrong

What did @dr.guilhermebraga actually say?

Honestly? It is nearly impossible to tell. The transcript attributed to this video is incoherent, consisting of fragmented, nonsensical sentences that do not convey any identifiable medical claim. Phrases like "I'll add any bit of the product to the product" and "you can do this will be" do not map onto any recognizable TRT talking point, dosing guidance, or clinical argument.

This appears to be a badly corrupted auto-transcription, likely generated from poor audio quality, background noise, or a non-English-primary speaker whose words were garbled by an automated speech-to-text tool. The video is tagged under TRT content and appears to be a response to user @Diego Lázaro, but without a clean transcript, we cannot confirm what specific claims, if any, were made about testosterone replacement therapy, hypogonadism, or hormone optimization.

Fact-checking a video requires a legible transcript. This one does not meet that threshold.

Does the science back this up?

There is no coherent claim here to evaluate against the literature. That said, since this video is categorized under TRT, it is worth establishing what the science actually says about testosterone replacement therapy, because the category itself is riddled with both legitimate research and significant overclaiming on social media.

Testosterone replacement therapy for clinically confirmed hypogonadism (defined as serum testosterone below 300 ng/dL with symptoms) has a reasonably solid evidence base. The Testosterone Trials, a coordinated set of seven placebo-controlled studies published in the New England Journal of Medicine (Snyder et al., 2016), found modest improvements in sexual function and bone density in older men with low testosterone, but no cardiovascular benefit and mixed results for energy and mood.

The broader "hormone optimization" framing common on social media, which implies TRT is appropriate for men with low-normal testosterone and vague symptoms, goes well beyond what that evidence supports. The Endocrine Society guidelines (Bhasin et al., 2018, Journal of Clinical Endocrinology and Metabolism) are explicit: TRT is indicated for confirmed hypogonadism, not general wellness.

What did they get wrong (or right)?

We cannot assign right or wrong to claims we cannot read. That is not a technicality. Reviewing garbled machine transcription as if it represents a creator's actual words would be irresponsible, both to the creator and to the viewer trying to get accurate information.

What we can say is this: the video sits in a content category, TRT advice on TikTok, where misinformation is genuinely common. A 2022 analysis in JAMA Internal Medicine (Murad et al.) found that health content on short-form video platforms frequently omits risks, cherry-picks outcomes, and conflates correlation with causation. TRT content specifically tends to overstate benefits for energy and muscle gain while underreporting risks like erythrocytosis, infertility from suppressed LH and FSH, and cardiovascular strain at supraphysiologic doses.

If @dr.guilhermebraga was making responsible claims in the actual video, credit is due. But the transcript as provided gives us nothing to work with, and we will not fabricate a review.

What should you actually know?

If you landed on this fact-check because you are considering TRT, here is what the literature actually supports. First, diagnosis matters more than symptoms alone. Low energy, reduced libido, and brain fog have dozens of causes. Before attributing them to low testosterone, a clinician should run morning serum testosterone on at least two separate occasions, along with LH, FSH, prolactin, and thyroid panels.

Second, TRT is not without risk. Exogenous testosterone suppresses the hypothalamic-pituitary axis, which means natural testosterone production stops and fertility is typically impaired during treatment. Hematocrit should be monitored regularly, as polycythemia is a documented adverse effect (Calof et al., 2005, Annals of Internal Medicine). Cardiovascular risk remains an area of active debate, with some observational data suggesting increased risk in certain populations.

Third, "optimization" is not a diagnosis. If a TikTok creator, or anyone else, is telling you that your testosterone could be "better" without referencing established clinical thresholds, that is a commercial framing, not a medical one.